142 related articles for article (PubMed ID: 1446256)
1. Perifusion system: its use in the study of the neuroendocrine control of human pituitary tumoral cells.
Joubert D; Brandi AM; Peillon F
Cell Biol Toxicol; 1992; 8(3):39-47. PubMed ID: 1446256
[No Abstract] [Full Text] [Related]
2. The dynamics of growth hormone and prolactin secretion in acromegalic patients with "mixed" pituitary tumours.
Lamberts SW; Klijn JG; Kwa GH; Birkenhäger JC
Acta Endocrinol (Copenh); 1979 Feb; 90(2):198-210. PubMed ID: 105530
[No Abstract] [Full Text] [Related]
3. Growth hormone and prolactin secretion of pituitary adenoma.
Yoshida J; Kageyama N; Seo H; Kanzaki M
Neurol Med Chir (Tokyo); 1975; 15 pt 1():13-21. PubMed ID: 60715
[No Abstract] [Full Text] [Related]
4. Roles and mechanisms of action of pituitary adenylate cyclase-activating polypeptide (PACAP) in growth hormone and prolactin secretion.
Murakami Y; Koshimura K; Yamauchi K; Nishiki M; Tanaka J; Kato Y
Endocr J; 2001 Apr; 48(2):123-32. PubMed ID: 11456257
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical studies of chromogranins (A and C) in pituitary adenomas.
Oda K; Inada K; Osamura RY
Pathol Res Pract; 1991 Jun; 187(5):626-8. PubMed ID: 1717962
[TBL] [Abstract][Full Text] [Related]
6. Bromocriptine inhibits prolactin and growth-hormone release by human pituitary tumours in culture.
Mashiter K; Adams E; Beard M; Holley A
Lancet; 1977 Jul; 2(8030):197-8. PubMed ID: 69814
[No Abstract] [Full Text] [Related]
7. [A case of thyrotropin-, growth hormone-, and prolactin-secreting pituitary adenoma with a remarkable response to long-acting somatostatin analogue (SMS201-995)].
Usui T; Sako Y; Matsumoto M; Kita T; Shimatsu A; Imura H
Nihon Naika Gakkai Zasshi; 1989 Nov; 78(11):1605-6. PubMed ID: 2614206
[No Abstract] [Full Text] [Related]
8. Dopaminergic inhibition of growth hormone and prolactin release during continuous in vitro perifusion of normal and adenomatous human pituitary.
Lawton NF; Evans AJ; Weller RO
J Neurol Sci; 1981 Feb; 49(2):229-39. PubMed ID: 7217982
[TBL] [Abstract][Full Text] [Related]
9. Light and electron microscopic observation of the same mammosomatotroph cell in a mixed growth hormone- and prolactin-secreting pituitary adenoma--case report.
Kabuto M; Kubota T; Kobayashi H; Nakagawa T
Neurol Med Chir (Tokyo); 1993 Apr; 33(4):238-41. PubMed ID: 7685856
[TBL] [Abstract][Full Text] [Related]
10. Bromocriptine-induced changes in hormone secretion and cell morphology in growth hormone and prolactin producing pituitary adenomas.
Anniko M; Werner S; Wersäll J
Acta Otolaryngol; 1981; 92(3-4):343-55. PubMed ID: 7324902
[No Abstract] [Full Text] [Related]
11. Mammosomatotroph adenoma of the pituitary associated with gigantism and hyperprolactinemia. A morphological study including immunoelectron microscopy.
Felix IA; Horvath E; Kovacs K; Smyth HS; Killinger DW; Vale J
Acta Neuropathol; 1986; 71(1-2):76-82. PubMed ID: 3776476
[TBL] [Abstract][Full Text] [Related]
12. Cytocidal effects of bromocriptine, somatostatin analog, and heat on growth hormone-secreting pituitary adenoma in vitro.
Kawamoto K; Uozumi T; Sakoda K; Mukada K; Kurisu K; Yano T
Cancer; 1992 Jun; 69(11):2688-96. PubMed ID: 1571899
[TBL] [Abstract][Full Text] [Related]
13. Pituitary function following surgery for prolactinomas.
Murray FT; Osterman J; Sulewski J; Page R; Bergland R; Hammond JM
Obstet Gynecol; 1979 Jul; 54(1):65-73. PubMed ID: 109802
[No Abstract] [Full Text] [Related]
14. Mammosomatotroph adenoma cells secrete both growth hormone and prolactin.
Kojima Y; Arita J; Kuwana N
Neurol Med Chir (Tokyo); 1995 Nov; 35(11):791-6. PubMed ID: 8657329
[TBL] [Abstract][Full Text] [Related]
15. Pituitary adenomas associated with hyperprolactinemia: a clinical and immunohistochemical study of 97 patients operated on transsphenoidally.
Randall RV; Scheithauer BW; Laws ER; Abbound CF; Ebersold MJ; Kao PC
Mayo Clin Proc; 1985 Nov; 60(11):753-62. PubMed ID: 3932786
[TBL] [Abstract][Full Text] [Related]
16. Prolactin and growth hormone responses to dermorphin in patients with prolactin-secreting pituitary adenoma.
degli Uberti EC; Trasforini G; Salvadori S; Margutti A; Rotola C; Bianconi M; Teodori V; Tomatis R; Pansini R
Metabolism; 1985 Sep; 34(9):874-9. PubMed ID: 4033428
[TBL] [Abstract][Full Text] [Related]
17. Human growth hormone releasing factor (hGRF) modulates calcium currents in human growth hormone secreting adenoma cells.
Chen C; Zhang J; McNeill P; Pullar M; Cummins JT; Clarke IJ
Brain Res; 1993 Feb; 604(1-2):345-8. PubMed ID: 8384513
[TBL] [Abstract][Full Text] [Related]
18. Immunoelectron microscopy for growth hormone and prolactin in pituitary adenomas.
Tomita T; Watanabe I; Rengachary SS
Hum Pathol; 1987 Apr; 18(4):367-74. PubMed ID: 3549533
[TBL] [Abstract][Full Text] [Related]
19. The role of octreotide (Sandostatin) in non-growth hormone-, non-thyroid-stimulating hormone-, and non-prolactin-secreting adenomas.
Warnet A
Metabolism; 1992 Sep; 41(9 Suppl 2):59-61. PubMed ID: 1325596
[TBL] [Abstract][Full Text] [Related]
20. Prolactin secretion and synthesis in short- and long-term organ culture of pituitary tumours from acromegalic patients.
Peillon F; Cesselin F; Garnier PE; Brandi AM; Donnadieu M; L'Hermite M; Dubois MP
Acta Endocrinol (Copenh); 1978 Apr; 87(4):701-15. PubMed ID: 347853
[No Abstract] [Full Text] [Related]
[Next] [New Search]
